Hypertensive chronic kidney disease
ICD-10 I12 is a used to indicate a diagnosis of hypertensive chronic kidney disease.
Hypertensive chronic kidney disease (CKD) is a condition characterized by the presence of chronic kidney disease in patients with hypertension. The kidneys, which play a crucial role in regulating blood pressure and fluid balance, can become damaged over time due to prolonged high blood pressure. This damage can lead to a decline in kidney function, often progressing through stages of CKD, from mild impairment to end-stage renal disease (ESRD). Clinically, patients may present with symptoms such as fatigue, swelling, and changes in urination patterns. The anatomy involved includes the renal arteries, nephrons, and glomeruli, which are essential for filtering blood and excreting waste. Disease progression is often insidious, with many patients remaining asymptomatic until significant kidney damage has occurred. Diagnostic considerations include blood pressure monitoring, serum creatinine levels, and urine tests to assess kidney function and proteinuria. Early detection and management of hypertension are critical to slowing the progression of CKD and preventing cardiovascular complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I12 covers hypertensive chronic kidney disease, which includes patients with hypertension who also have chronic kidney disease, classified by stages (I-IV) based on the level of kidney function impairment.
I12 should be used when a patient has both hypertension and chronic kidney disease. If only hypertension is present without CKD, code I10 should be used. If CKD is present without hypertension, use N18 codes.
Documentation should include a confirmed diagnosis of hypertension, evidence of chronic kidney disease (such as lab results indicating decreased GFR), and any treatment plans addressing both conditions.
